Neonatal host defense against staphylococcal infections

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Power Coombs, Melanie R ^a   Kronforst, Kenny ^b,c   Levy, Ofer ^d,e  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; DEFENSIN; INTERLEUKIN 10; INTERLEUKIN 23; INTERLEUKIN 6; LACTOFERRIN; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; SECRETORY PHOSPHOLIPASE A2; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; BACTERIAL CLEARANCE; BACTERIAL LOAD; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; INFLAMMATION; INNATE IMMUNITY; INTERFERON PRODUCTION; LEUKOCYTE; NEUTROPHIL; PHAGOCYTE; PHAGOCYTOSIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; REVIEW; STAPHYLOCOCCUS INFECTION; VERTICAL TRANSMISSION; VULNERABLE POPULATION; IMMUNOLOGY; METABOLISM; NEWBORN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; INFANT, PREMATURE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TOLL-LIKE RECEPTORS;

EID: 84880909338     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/826303     Document Type: Review

References (109)

1. Lawn J. E., Cousens S., Zupan J., 4 million neonatal deaths: when? where? why? The Lancet 2005 365 9462 891 900 2-s2.0-14744298742 10.1016/S0140-6736(05) 71048-5 (Pubitemid 40332168)
2. Horbar J. D., Rogowski J., Plsek P. E., Delmore P., Edwards W. H., Hocker J., Kantak A. D., Lewallen P., Lewis W., Lewit E., McCarroll C. J., Mujsce D., Payne N. R., Shiono P., Soll R. F., Leahy K., Carpenter J. H., Collaborative quality improvement for neonatal intensive care. Pediatrics 2001 107 1 14 22 2-s2.0-17744379181 10.1542/peds.107.1.14 (Pubitemid 32055409)
3. Bersani I., Speer C. P., Nosocomial sepsis in neonatal intensive care: inevitable or preventable? Zeitschrift für Geburtshilfe und Neonatologie 2012 216 4 186 190 10.1055/s-0032-1321837
4. Rogowski J. A., Horbar J. D., Plsek P. E., Baker L. S., Deterding J., Edwards W. H., Hocker J., Kantak A. D., Lewallen P., Lewis W., Lewit E., McCarroll C. J., Mujsce D., Payne N. R., Shiono P., Soll R. F., Leahy K., Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics 2001 107 1 23 29 2-s2.0-17744396474 10.1542/peds.107.1. 23 (Pubitemid 32055410)
5. Keyworth N., Millar M. R., Holland K. T., Development of cutaneous microflora in premature neonates. Archives of Disease in Childhood 1992 67 7 797 801 2-s2.0-0026770427
6. Cheung G. Y. C., Otto M., Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children. Current Opinion in Infectious Diseases 2010 23 3 208 216 2-s2.0-77951604601 10.1097/QCO. 0b013e328337fecb
7. Kloos W. E., Musselwhite M. S., Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Journal of Applied Microbiology 1975 30 3 381 395 2-s2.0-0016762430
8. Gray J. E., Richardson D. K., McCormick M. C., Goldmann D. A., Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995 95 2 225 230 2-s2.0-0028900921
9. Payne N. R., Carpenter J. H., Badger G. J., Horbar J. D., Rogowski J., Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004 114 2 348 355 2-s2.0-3442889070 10.1542/peds.114.2.348 (Pubitemid 39006660)
10. Gonzalez A., Sosenko I. R. S., Chandar J., Hummler H., Claure N., Bancalari E., Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. The Journal of Pediatrics 1996 128 4 470 478 2-s2.0-0029994958 10.1016/S0022-3476(96)70356-6 (Pubitemid 26114083)
11. Liljedahl M., Bodin L., Schollin J., Coagulase-negative staphylococcal sepsis as a predictor of bronchopulmonary dysplasia. Acta Paediatrica 2004 93 2 211 215 2-s2.0-1242337457 10.1080/08035250310008168 (Pubitemid 38230717)
12. Stoll B. J., Hansen N. I., Adams-Chapman I., Fanaroff A. A., Hintz S. R., Vohr B., Higgins R. D., Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. Journal of the American Medical Association 2004 292 19 2357 2365 2-s2.0-8544252449 10.1001/jama.292.19.2357 (Pubitemid 39491920)
13. Martin C. R., Dammann O., Allred E. N., Patel S., O'Shea T. M., Kuban K. C. K., Leviton A., Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia. The Journal of Pediatrics 2010 157 5 751.e1 756.e1 2-s2.0-77958075431 10.1016/j.jpeds.2010.05. 042
14. Bizzarro M. J., Raskind C., Baltimore R. S., Gallagher P. G., Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005 116 3 595 602 2-s2.0-33644616250 10.1542/peds.2005-0552 (Pubitemid 44336674)
15. Isaacs D., A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Archives of Disease in Childhood 2003 88 2 F89 F93 2-s2.0-0037374601 (Pubitemid 36269526)
16. Shane A. L., Stoll B. J., Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. American Journal of Perinatology 2013 30 2 131 141 10.1055/s-0032-1333413
17. Isayama T., Lee S. K., Mori R., Kusuda S., Fujimura M., Ye X. Y., Shah P. S., Comparison of mortality and morbidity of very low birth weight infants between Canada and Japan. Pediatrics 2012 130 4 e957 e965 10.1542/peds.2012-0336
18. Vuong C., Otto M., Staphylococcus epidermidis infections. Microbes and Infection 2002 4 4 481 489 2-s2.0-0036217211 10.1016/S1286-4579(02)01563-0 (Pubitemid 34270685)
19. Boghossian N. S., Page G. P., Bell E. F., Stoll B. J., Murray J. C., Cotten C. M., Shankaran S., Walsh M. C., Laptook A. R., Newman N. S., Hale E. C., McDonald S. A., Das A., Higgins R. D., Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. The Journal of Pediatrics 2013 10.1016/j.jpeds.2012.11.089
20. Mueller-Premru M., Gubina M., Kaufmann M. E., Use of semi-quantitative and quantitative culture methods and typing for studying the epidemiology of central venous catheter-related infections in neonates on parenteral nutrition. Journal of Medical Microbiology 1999 48 5 451 460 2-s2.0-0032814497 (Pubitemid 29371584)
21. O'Gara J. P., Humphreys H., Staphylococcus epidermidis biofilms: importance and implications. Journal of Medical Microbiology 2001 50 7 582 587 2-s2.0-0034948548 (Pubitemid 32588152)
22. Okada Y., Klein N. J., van Saene H. K. F., Webb G., Holzel H., Pierro A., Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition. Annals of Surgery 2000 231 2 276 281 2-s2.0-0033974333 10.1097/00000658-200002000-00018 (Pubitemid 30078812)
23. Dimitriou G., Fouzas S., Giormezis N., Giannakopoulos I., Tzifas S., Foka A., Anastassiou D. E., Spiliopoulou I., Mantagos S., Clinical and microbiological profile of persistent coagulase-negative staphylococcal bacteraemia in neonates. Clinical Microbiology and Infection 2011 17 11 1684 1690 10.1111/j.1469-0691.2011.03489.x
24. Stoll B. J., Hansen N., Fanaroff A. A., Wright L. L., Carlo W. A., Ehrenkranz R. A., Lemons J. A., Donovan E. F., Stark A. R., Tyson J. E., Oh W., Bauer C. R., Korones S. B., Shankaran S., Laptook A. R., Stevenson D. K., Papile L. A., Kenneth Poole W., Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002 110 2 285 291 2-s2.0-18444388276 10.1542/peds.110.2.285 (Pubitemid 34833012)
25. Orsi G. B., d'Ettorre G., Panero A., Chiarini F., Vullo V., Venditti M., Hospital-acquired infection surveillance in a neonatal intensive care unit. American Journal of Infection Control 2009 37 3 201 203 2-s2.0-63149189348 10.1016/j.ajic.2008.05.009
26. Lim W. H., Lien R., Huang Y. C., Chiang M. C., Fu R. H., Chu S. M., Hsu J. F., Yang P. H., Prevalence and pathogen distribution of neonatal sepsis among very-low-birth-weight infants. Pediatrics & Neonatology 2012 53 4 228 234 10.1016/j.pedneo.2012.06.003
27. Wang X., Mallard C., Levy O., Potential role of coagulase-negative Staphylococcus infection in preterm brain injury. Advances in Neuroimmune Biology 2012 3 1 41 48
28. Healy C. M., Hulten K. G., Palazzi D. L., Campbell J. R., Baker C. J., Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clinical Infectious Diseases 2004 39 10 1460 1466 2-s2.0-8744260999 10.1086/425321 (Pubitemid 39518209)
29. Mhada T. V., Fredrick F., Matee M. I., Massawe A., Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome. BMC Public Health 2012 12, article 904 10.1186/1471-2458-12-904
30. Ho T. S., Wang S. M., Wu Y. H., Shen C. F., Lin Y. J., Lin C. H., Liu C. C., Long-term characteristics of healthcare-associated infections in a neonatal intensive care unit. Journal of Microbiology, Immunology and Infection 2010 43 5 407 415 2-s2.0-78049368503 10.1016/S1684-1182(10)60064-3
31. Kamath S., Mallaya S., Shenoy S., Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram. Indian Journal of Pediatrics 2010 77 1 37 39 2-s2.0-76649125921 10.1007/s12098-010- 0005-5
32. Jimenez-Truque N., Tedeschi S., Saye E. J., McKenna B. D., Langdon W., Wright J. P., Alsentzer A., Arnold S., Saville B. R., Wang W., Thomsen I., Creech C. B., Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 2012 129 5 e1252 e1259 10.1542/peds.2011-2308
33. Lazenby G. B., Soper D. E., Beardsley W., Salgado C. D., Methicillin-resistant Staphylococcus aureus colonization among women admitted for preterm delivery. American Journal of Obstetrics & Gynecology 2012 206 4 329.e1 329.e5 10.1016/j.ajog.2012.01.038
34. Kollmann T. R., Levy O., Montgomery R. R., Goriely S., Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012 37 5 771 783 10.1016/j.immuni.2012.10.014
35. Cuenca A. G., Wynn J. L., Moldawer L. L., Levy O., Role of innate immunity in neonatal infection. American Journal of Perinatology 2013 30 2 105 112 10.1055/s-0032-1333412
36. Levy O., Innate immunity of the newborn: basic mechanisms and clinical correlates. Nature Reviews Immunology 2007 7 5 379 390 2-s2.0-34247588114 10.1038/nri2075 (Pubitemid 46674489)
37. Belderbos M. E., Levy O., Meyaard L., Bont L., Plasma-mediated immune suppression: a neonatal perspective. Pediatric Allergy and Immunology 2012 24 2 102 113
38. Levy O., Coughlin M., Cronstein B. N., Roy R. M., Desai A., Wessels M. R., The adenosine system selectively inhibits TLR-mediated TNF- α production in the human newborn. The Journal of Immunology 2006 177 3 1956 1966 2-s2.0-33746214770 (Pubitemid 44092536)
39. Angelone D. F., Wessels M. R., Coughlin M., Suter E. E., Valentini P., Kalish L. A., Levy O., Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF- α production in vitro and in vivo. Pediatric Research 2006 60 2 205 209 2-s2.0-33747161725 10.1203/01.pdr.0000228319.10481.ea (Pubitemid 44297594)
40. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X. F., Achong M. K., IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. The Journal of Clinical Investigation 1998 101 2 311 320 2-s2.0-0032518415 (Pubitemid 28067327)
41. Fielding C. A., McLoughlin R. M., McLeod L., Colmont C. S., Najdovska M., Grail D., Ernst M., Jones S. A., Topley N., Jenkins B. J., IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. The Journal of Immunology 2008 181 3 2189 2195 2-s2.0-49649104776
42. Jones S. A., Directing transition from innate to acquired immunity: defining a role for IL-6. The Journal of Immunology 2005 175 6 3463 3468 2-s2.0-24744435772 (Pubitemid 41292002)
43. Levy O., Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 2000 96 8 2664 2672 2-s2.0-0034667551
44. Levy O., Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. Journal of Leukocyte Biology 2004 76 5 909 925 2-s2.0-7644238048 10.1189/jlb.0604320 (Pubitemid 39458703)
45. Levy O., Gallo R. L., A pediatric perspective on antimicrobial proteins and peptides: expression, function, and clinical relevance. Antimicrobial Peptides in Human Health and Disease 2005 Norfolk, UK Horizon Bioscience 305 329
46. Vogel H. J., Lactoferrin, a bird's eye view. Biochemistry and Cell Biology 2012 90 3 233 244 10.1139/o2012-016
47. Callewaert L., Michiels C. W., Lysozymes in the animal kingdom. Journal of Biosciences 2010 35 1 127 160 2-s2.0-77951759131 10.1007/s12038-010-0015-5
48. Pinheiro da Silva F., Machado M. C., Antimicrobial peptides: clinical relevance and therapeutic implications. Peptides 2012 36 2 308 314 10.1016/j.peptides.2012.05.014
49. Lehrer R. I., Ganz T., Defensins of vertebrate animals. Current Opinion in Immunology 2002 14 1 96 102 2-s2.0-0036467390 10.1016/S0952-7915(01)00303-X (Pubitemid 34085112)
50. Yost C. C., Cody M. J., Harris E. S., Thornton N. L., McInturff A. M., Martinez M. L., Chandler N. B., Rodesch C. K., Albertine K. H., Petti C. A., Weyrich A. S., Zimmerman G. A., Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood 2009 113 25 6419 6427 2-s2.0-67650638848 10.1182/blood-2008-07-171629
51. Strunk T., Doherty D., Richmond P., Simmer K., Charles A., Levy O., Liyanage K., Smith T., Currie A., Burgner D., Reduced levels of antimicrobial proteins and peptides in human cord blood plasma. Archives of Disease in Childhood 2009 94 3 F230 F231 2-s2.0-67650093206 10.1136/adc.2008.143438
52. Davis C. A., Vallota E. H., Forristal J., Serum complement levels in infancy: age related changes. Pediatric Research 1979 13 9 1043 1046 2-s2.0-0018396839 (Pubitemid 9218583)
53. Nittala S., Subbarao G. C., Maheshwari A., Evaluation of neutropenia and neutrophilia in preterm infants. The Journal of Maternal-Fetal & Neonatal Medicine 2012 25 supplement 5 100 103
54. Filias A., Theodorou G. L., Mouzopoulou S., Varvarigou A. A., Mantagos S., Karakantza M., Phagocytic ability of neutrophils and monocytes in neonates. BMC Pediatrics 2011 11, article 29 2-s2.0-79953842950 10.1186/1471-2431-11-29
55. Gessler P., Nebe T., Birle A., Haas N., Kachel W., Neutrophil respiratory burst in term and preterm neonates without signs of infection and in those with increased levels of C-reactive protein. Pediatric Research 1996 39 5 843 848 2-s2.0-0029936556 (Pubitemid 26130025)
56. Bektas S., Goetze B., Speer C. P., Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates. Acta Paediatrica Scandinavica 1990 79 11 1031 1038 2-s2.0-0025038572 (Pubitemid 20335813)
57. Björkqvist M., Jurstrand M., Bodin L., Fredlund H., Schollin J., Defective neutrophil oxidative burst in preterm newborns on exposure to coagulase-negative staphylococci. Pediatric Research 2004 55 6 966 971 2-s2.0-2442697678 10.1203/01.pdr.0000127018.44938.89 (Pubitemid 38661788)
58. Lavoie P. M., Huang Q., Jolette E., Whalen M., Nuyt A. M., Audibert F., Speert D. P., Lacaze-Masmonteil T., Soudeyns H., Kollmann T. R., Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. Journal of Infectious Diseases 2010 202 11 1754 1763 2-s2.0-78649565977 10.1086/657143
59. Walk J., Westerlaken G. H., van Uden N. O., Belderbos M. E., Meyaard L., Bont L. J., Inhibitory receptor expression on neonatal immune cells. Clinical & Experimental Immunology 2012 169 2 164 171 10.1111/j.1365-2249.2012.04599. x
60. Kondo T., Kawai T., Akira S., Dissecting negative regulation of Toll-like receptor signaling. Trends in Immunology 2012 33 9 449 458 10.1016/j.it.2012. 05.002
61. Kawai T., Akira S., Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011 34 5 637 650 2-s2.0-79956300649 10.1016/j.immuni.2011.05.006
62. Dasari P., Zola H., Nicholson I. C., Expression of Toll-like receptors by neonatal leukocytes. Pediatric Allergy and Immunology 2011 22 2 221 228 2-s2.0-79951795840 10.1111/j.1399-3038.2010.01091.x
63. Levy O., Zarember K. A., Roy R. M., Cywes C., Godowski P. J., Wessels M. R., Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF- α induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. The Journal of Immunology 2004 173 7 4627 4634 2-s2.0-4644307506 (Pubitemid 39280696)
64. Sadeghi K., Berger A., Langgartner M., Prusa A. R., Hayde M., Herkner K., Pollak A., Spittler A., Förster-Waldl E., Immaturity of infection control in preterm and term newborns is associated with impaired Toll-like receptor signaling. Journal of Infectious Diseases 2007 195 2 296 302 2-s2.0-33846122960 10.1086/509892 (Pubitemid 46080062)
65. Tissieres P., Ochoda A., Dunn-Siegrist I., Drifte G., Morales M., Pfister R., Berner M., Pugin J., Innate immune deficiency of extremely premature neonates can be reversed by interferon-gamma. PLoS ONE 2012 7 3 e32863 10.1371/journal.pone.0032863
66. Förster-Waldl E., Sadeghi K., Tamandl D., Gerhold B., Hallwirth U., Rohrmeister K., Hayde M., Prusa A. R., Herkner K., Boltz-Nitulescu G., Pollak A., Spittler A., Monocyte Toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatric Research 2005 58 1 121 124 2-s2.0-22044458575 10.1203/01.PDR.0000163397.53466.0F (Pubitemid 40967441)
67. Zhang J. P., Yang Y., Levy O., Chen C., Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo. Pediatric Research 2010 68 6 479 483 2-s2.0-78649351618 10.1203/PDR.0b013e3181f90810
68. Zhang J. P., Chen C., Yang Y., Changes and clinical significance of Toll-like receptor 2 and 4 expression in neonatal infections. Zhonghua Er Ke Za Zhi 2007 45 2 130 133 2-s2.0-77953079230
69. Al-Hertani W., Yan S. R., Byers D. M., Bortolussi R., Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide. Clinical and Investigative Medicine 2007 30 2 E44 E53 2-s2.0-35148826063 (Pubitemid 47535692)
70. Yan S. R., Qing G., Byers D. M., Stadnyk A. W., Al-Hertani W., Bortolussi R., Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infection and Immunity 2004 72 3 1223 1229 2-s2.0-1342323844 10.1128/IAI.72.3.1223-1229.2004 (Pubitemid 38263739)
71. Corbett N. P., Blimkie D., Ho K. C., Cai B., Sutherland D. P., Kallos A., Crabtree J., Rein-Weston A., Lavoie P. M., Turvey S. E., Hawkins N. R., Self S. G., Wilson C. B., Hajjar A. M., Fortuno E. S. III, Kollmann T. R., Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 2010 5 11 e15041 10.1371/journal.pone.0015041
72. Lederhuber H., Baer K., Altiok I., Sadeghi K., Herkner K. R., Kasper D. C., MicroRNA-146: tiny player in neonatal innate immunity? Neonatology 2011 99 1 51 56 2-s2.0-77954272886 10.1159/000301938
73. Strunk T., Power Coombs M. R., Currie A. J., Richmond P., Golenbock D. T., Stoler-Barak L., Gallington L. C., Otto M., Burgner D., Levy O., TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS ONE 2010 5 4 2-s2.0-77956328207 10.1371/journal.pone.0010111 e10111
74. Yoshimura A., Lien E., Ingalls R. R., Tuomanen E., Dziarski R., Golenbock D., Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. The Journal of Immunology 1999 163 1 1 5 2-s2.0-0033168728 (Pubitemid 29295815)
75. Takeuchi O., Hoshino K., Akira S., Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. The Journal of Immunology 2000 165 10 5392 5396 2-s2.0-0034669910
76. Kochan T., Singla A., Tosi J., Kumar A., Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infection and Immunity 2012 80 6 2076 2088 10.1128/IAI.00149-12
77. Strunk T., Richmond P., Prosser A., Simmer K., Levy O., Burgner D., Currie A., Method of bacterial killing differentially affects the human innate immune response to Staphylococcus epidermidis. Innate Immunity 2011 17 6 508 516 10.1177/1753425910379840
78. Kronforst K. D., Mancuso C. J., Pettengill M., Ninkovic J., Power Coombs M. R., Stevens C., Otto M., Mallard C., Wang X., Goldmann D., Levy O., A neonatal model of intravenous Staphylococcus epidermidis infection in mice LTHEXA 24 h old enables characterization of early innate immune responses. PLoS ONE 2012 7 9 e43897 10.1371/journal.pone.0043897
79. Härtel C., Osthues I., Rupp J., Haase B., Röder K., Göpel W., Herting E., Schultz C., Characterisation of the host inflammatory response to Staphylococcus epidermidis in neonatal whole blood. Archives of Disease in Childhood 2008 93 2 F140 F145 2-s2.0-41449107490 10.1136/adc.2007.124685 (Pubitemid 352038505)
80. Peoples J. D., Cheung S., Nesin M., Lin H., Francesca Tatad A. M., Hoang D., Perlman J. M., Cunningham-Rundles S., Neonatal cord blood subsets and cytokine response to bacterial antigens. American Journal of Perinatology 2009 26 9 647 657 2-s2.0-70449486714 10.1055/s-0029-1220788
81. Tatad A. M. F., Nesin M., Peoples J., Cheung S., Lin H., Sison C., Perlman J., Cunningham-Rundles S., Cytokine expression in response to bacterial antigens in preterm and term infant cord blood monocytes. Neonatology 2008 94 1 8 15 2-s2.0-46049116658 10.1159/000112541 (Pubitemid 351896588)
82. Mohamed M. A., Cunningham-Rundles S., Dean C. R., Hammad T. A., Nesin M., Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls. Cytokine 2007 39 3 171 177 2-s2.0-35349027268 10.1016/j.cyto.2007.07.004 (Pubitemid 47599969)
83. Strunk T., Prosser A., Levy O., Philbin V., Simmer K., Doherty D., Charles A., Richmond P., Burgner D., Currie A., Responsiveness of human monocytes to the commensal bacterium Staphylococcus epidermidis develops late in gestation. Pediatric Research 2012 72 10 18 10.1038/pr.2012.48
84. Thammavongsa V., Schneewind O., Missiakas D. M., Enzymatic properties of Staphylococcus aureus adenosine synthase (AdsA). BMC Biochemistry 2011 12, article 56 10.1186/1471-2091-12-56
85. Schwaninger M., Neher M., Viegas E., Schneider A., Spranger M., Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine. Journal of Neurochemistry 1997 69 3 1145 1150 2-s2.0-0030755898 (Pubitemid 27364835)
86. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X. F., Achong M. K., IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. The Journal of Clinical Investigation 1998 101 2 311 320 2-s2.0-0032518415 (Pubitemid 28067327)
87. Fiebich B. L., Biber K., Gyufko K., Berger M., Bauer J., van Calker D., Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. Journal of Neurochemistry 1996 66 4 1426 1431 2-s2.0-0029670366
88. Ritchie P. K., Spangelo B. L., Krzymowski D. K., Rossiter T. B., Kurth E., Judd A. M., Adenosine increases interleukin 6 release and decreases tumour necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages. Cytokine 1997 9 3 187 198 2-s2.0-0031106065 10.1006/cyto.1996.0153 (Pubitemid 27152063)
89. Le Vraux V., Chen Y. L., Masson I., De Sousa M., Giroud J. P., Florentin I., Chauvelot-Moachon L., Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sciences 1993 52 24 1917 1924 2-s2.0-0027154950 10.1016/0024-3205(93)90632-D
90. Prabhakar U., Brooks D. P., Lipshlitz D., Esser K. M., Inhibition of LPS-induced TNF α production in human monocytes byadenosine (A2) receptor selective agonists. International Journal of Immunopharmacology 1995 17 3 221 224 2-s2.0-0028987112 10.1016/0192-0561(94)00096-7
91. Ferrante A., Nandoskar M., Walz A., Goh D. H. B., Kowanko I. C., Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. International Archives of Allergy and Applied Immunology 1988 86 1 82 91 2-s2.0-0023909920
92. Hemels M. A. C., Verboon-Maciolek M. A., Gerards L. J., Krediet T. G., Fleer A., Rapid clearance from the bloodstream of coagulase-negative staphylococci in infants with late-onset sepsis. Pediatric Infectious Disease Journal 2009 28 9 853 854 2-s2.0-70249125479 10.1097/INF.0b013e3181b20ea9
93. Wiederhold N. P., Coyle E. A., Raad I. I., Prince R. A., Lewis R. E., Antibacterial activity of linezolid and vancomycin in an vitro pharmacodynamic model of Gram-positive catheter-related bacteraemia. Journal of Antimicrobial Chemotherapy 2005 55 5 792 795 2-s2.0-18844393451 10.1093/jac/dki106 (Pubitemid 40691865)
94. Raad I., Hanna H., Jiang Y., Dvorak T., Reitzel R., Chaiban G., Sherertz R., Hachem R., Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrobial Agents and Chemotherapy 2007 51 5 1656 1660 2-s2.0-34248399494 10.1128/AAC.00350-06 (Pubitemid 46744141)
95. Rasigade J. P., Raulin O., Picaud J. C., Tellini C., Bes M., Grando J., Ben Said M., Claris O., Etienne J., Tigaud S., Laurent F., Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates. PLoS ONE 2012 7 2 e31548 10.1371/journal.pone.0031548
96. Placencia F. X., Kong L., Weisman L. E., Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin. Pediatric Research 2009 65 4 420 424 2-s2.0-65349104002 10.1203/PDR.0b013e3181994a53
97. Carr R., Brocklehurst P., Doré C. J., Modi N., Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. The Lancet 2009 373 9659 226 233 2-s2.0-58149464319 10.1016/S0140-6736(09)60071- 4
98. Ahmad M., Fleit H. B., Golightly M. G., La Gamma E. F., In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates. Biology of the Neonate 2004 86 1 48 54 2-s2.0-4043116165 10.1159/000077585 (Pubitemid 39077610)
99. DeJonge M., Burchfield D., Bloom B., Duenas M., Walker W., Polak M., Jung E., Millard D., Schelonka R., Eyal F., Morris A., Kapik B., Roberson D., Kesler K., Patti J., Hetherington S., Clinical trial of safety and efficacy of IHN-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. The Journal of Pediatrics 2007 151 3 260.e1 265.e1 2-s2.0-34548048636 10.1016/j.jpeds.2007.04.060 (Pubitemid 47284140)
100. Benjamin D. K., Schelonka R., White R., Holley H. P., Bifano E., Cummings J., Adcock K., Kaufman D., Puppala B., Riedel P., Hall B., White J., Cotten C. M., Anstrom K., Charny M., Fowler V., Haubner L., Horwith G., LeBlanc M., Naveed H., Papile L. A., Petrycki S., Rosenberg A., Rozycki H., Stevens T., Veney N., Visveshwara N., Zenge J., A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin. Journal of Perinatology 2006 26 5 290 295 2-s2.0-33646116056 10.1038/sj.jp.7211496
101. Bloom B., Schelonka R., Kueser T., Walker W., Jung E., Kaufman D., Kesler K., Roberson D., Patti J., Hetherington S., Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatric Infectious Disease Journal 2005 24 10 858 866 2-s2.0-26944498224 10.1097/01.inf.0000180504.66437.1f (Pubitemid 41475919)
102. Netea M. G., Quintin J., van der Meer J. W. M., Trained immunity: a memory for innate host defense. Cell Host and Microbe 2011 9 5 355 361 2-s2.0-79956080152 10.1016/j.chom.2011.04.006
103. Wynn J. L., Scumpia P. O., Winfield R. D., Delano M. J., Kelly-Scumpia K., Barker T., Ungaro R., Levy O., Moldawer L. L., Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008 112 5 1750 1758 2-s2.0-52649156933 10.1182/blood-2008-01- 130500
104. Levin M., Quint P. A., Goldstein B., Barton P., Bradley J. S., Shemie S. D., Yeh T., Kim S. S., Cafaro D. P., Scannon P. J., Giroir B. P., Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. The Lancet 2000 356 9234 961 967 2-s2.0-0034675328
105. Guinan E. C., Barbon C. M., Kalish L. A., Parmar K., Kutok J., Mancuso C. J., Stoler-Barak L., Suter E. E., Russell J. D., Palmer C. D., Gallington L. C., Voskertchian A., Vergilio J. A., Cole G., Zhu K., 'Andrea A. D., Soiffer R., Weiss J. P., Levy O., Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death. Science Translational Medicine 2011 3 110 110ra118 10.1126/scitranslmed.3003126
106. Weinrauch Y., Elsbach P., Madsen L. M., Foreman A., Weiss J., The potent anti- Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. The Journal of Clinical Investigation 1996 97 1 250 257 2-s2.0-0030070567 (Pubitemid 26021715)
107. Yen C. C., Lin C. Y., Chong K. Y., Tsai T. C., Shen C. J., Lin M. F., Su C. Y., Chen H. L., Chen C. M., Lactoferrin as a natural regimen for selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogenic challenge in the gastrointestinal tract. Journal of Infectious Diseases 2009 199 4 590 598 2-s2.0-61849184878 10.1086/596212
108. Otto M., MRSA virulence and spread. Cellular Microbiology 2012 14 10 1513 1521 10.1111/j.1462-5822.2012.01832.x
109. Otto M., Molecular basis of Staphylococcus epidermidis infections. Seminars in Immunopathology 2012 34 2 201 214 10.1007/s00281-011-0296-2